Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Postoperative adjuvant chemotherapy improves survival after surgical resection for pancreatic carcinoma.

Postoperative adjuvant chemotherapy improves survival after surgical resection for pancreatic carcinoma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Postoperative adjuvant chemotherapy improves survival after surgical resection for pancreatic carcinoma. Abstract Text:

    yoshiaki murakamiYoshiaki Murakami,kenichiro uemuraKenichiro Uemura,takeshi sudoTakeshi Sudo,yasuo hayashidaniYasuo Hayashidani,yasushi hashimotoYasushi Hashimoto,hiroki ohgeHiroki Ohge,taijiro suedaTaijiro Sueda,

    Pancreatic carcinoma is one of the most aggressive types of gastrointestinal malignancy, and its prognosis remains extremely dismal. The aim of this study was to identify useful prognostic factors for patients undergoing surgical resection for pancreatic carcinoma. Medical records of 89 patients with pancreatic carcinoma who underwent surgical resection were retrospectively reviewed. Univariate and multivariate models were used to analyze the effect of various clinicopathological factors on long-term survival. There were no operative deaths. Overall 1-, 2-, and 5-year survival rates were 59, 28, and 7%, respectively (median survival time, 12.1 months). Univariate analysis revealed that postoperative adjuvant chemotherapy, portal vein invasion, lymph node metastasis, extrapancreatic nerve plexus invasion, surgical margin status, UICC pT factor, and UICC stage were significantly associated with long-term survival (P < 0.01). Furthermore, use of postoperative adjuvant chemotherapy and absence of extrapancreatic nerve plexus invasion were found to be significant independent predictors of a favorable prognosis using a Cox proportional hazard regression model (P < 0.05). These results suggest that postoperative adjuvant chemotherapy may improve survival after surgical resection for pancreatic carcinoma and that extrapancreatic nerve plexus invasion indicates a poor prognosis for long-term survival.

    Postoperative adjuvant chemotherapy improves survival after surgical resection for pancreatic carcinoma. Publishing Authors By Initials

    y murakamiY Murakami,k uemuraK Uemura,t sudoT Sudo,y hayashidaniY Hayashidani,y hashimotoY Hashimoto,h ohgeH Ohge,t suedaT Sueda,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Postoperative adjuvant chemotherapy improves survival after surgical resection for pancreatic carcinoma. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Journal of gastrointestinal surgery : official jou

    VOLUME: 12

    Page Numbers: 534-41

    Journal Abbreviation: J. Gastrointest. Surg.

    ISSN: 1091-255X

    DAY: 17

    MONTH: 11

    YEAR: 2007

    Postoperative adjuvant chemotherapy improves survival after surgical resection for pancreatic carcinoma. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9706084

    Postoperative adjuvant chemotherapy improves survival after surgical resection for pancreatic carcinoma. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Postoperative adjuvant chemotherapy improves survival after surgical resection for pancreatic carcinoma. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Postoperative adjuvant chemotherapy improves survival after surgical resection for pancreatic carcinoma.

    AFFILIATION: Department of Surgery, Division of Clinical Medical Science, Graduate School of Biomedical Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan, mura777@hiroshima-u.ac.jp.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Gastrointest Surg

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Postoperative adjuvant chemotherapy improves survival after surgical resection for pancreatic carcinoma Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News